Zeria Pharmaceutical Co (TSE:4559) E10: 円125.68 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4559 Zeria Pharmaceutical Co Ltd TSE:4559
85 GF Score
Price 円2,087.00
GF Value 円2,506.68
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Zeria Pharmaceutical Co E10?

Zeria Pharmaceutical Co TSE:4559 +1.61% 85 E10 is 円125.68 as of Mar. 2026. GuruFocus rates TSE:4559 with a GF Score™ of 85/100 and a GF Value™ of 円2,506.68 (Modestly Undervalued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Zeria Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2026 was 円65.800. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is 円125.68 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Zeria Pharmaceutical Co's average E10 Growth Rate was 11.80% per year. During the past 3 years, the average E10 Growth Rate was 14.20% per year. During the past 5 years, the average E10 Growth Rate was 11.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Zeria Pharmaceutical Co was 14.20% per year. The lowest was 4.50% per year. And the median was 6.30% per year.

As of today (2026-07-21), Zeria Pharmaceutical Co's current stock price is 円2087.00. Zeria Pharmaceutical Co's E10 for the quarter that ended in Mar. 2026 was 円125.68. Zeria Pharmaceutical Co's Shiller PE Ratio of today is 16.61.

During the past 13 years, the highest Shiller PE Ratio of Zeria Pharmaceutical Co was 37.51. The lowest was 16.22. And the median was 26.51.


Zeria Pharmaceutical Co  (TSE:4559) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Zeria Pharmaceutical Co's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=2087.00/125.68
=16.61

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Zeria Pharmaceutical Co was 37.51. The lowest was 16.22. And the median was 26.51.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Zeria Pharmaceutical Co E10 Related Terms


Zeria Pharmaceutical Co E10 Historical Data

* Premium members only.

The historical data trend for Zeria Pharmaceutical Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zeria Pharmaceutical Co E10 Chart

Zeria Pharmaceutical Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 77.44 84.49 91.67 112.46 125.68

Zeria Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 112.46 113.64 113.86 119.81 125.68

TSE:4559 vs ZTS, UTHR: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Zeria Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zeria Pharmaceutical Co Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zeria Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Zeria Pharmaceutical Co's Shiller PE Ratio falls into.


TSE:4559
85GF Score
Zeria Pharmaceutical Co Ltd TSE:4559
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zeria Pharmaceutical Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Zeria Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=65.8/112.7000*112.7000
=65.800

Current CPI (Mar. 2026) = 112.7000.

Zeria Pharmaceutical Co Quarterly Data

per share eps CPI Adj_EPS
201606 25.010 98.100 28.732
201609 12.770 98.000 14.686
201612 16.320 98.400 18.692
201703 12.626 98.100 14.505
201706 12.390 98.500 14.176
201709 28.310 98.800 32.293
201712 35.650 99.400 40.420
201803 4.024 99.200 4.572
201806 44.590 99.200 50.658
201809 0.722 99.900 0.815
201812 12.560 99.700 14.198
201903 11.542 99.700 13.047
201906 24.140 99.800 27.260
201909 1.812 100.100 2.040
201912 23.820 100.500 26.712
202003 12.640 100.300 14.203
202006 21.020 99.900 23.713
202009 9.007 99.900 10.161
202012 50.130 99.300 56.895
202103 -12.232 99.900 -13.799
202106 30.910 99.500 35.011
202109 15.677 100.100 17.650
202112 42.680 100.100 48.052
202203 -1.856 101.100 -2.069
202206 58.710 101.800 64.996
202209 31.653 103.100 34.600
202212 44.900 104.100 48.609
202303 4.878 104.400 5.266
202306 66.140 105.200 70.855
202309 56.290 106.200 59.735
202312 68.660 106.800 72.453
202403 -15.700 107.200 -16.506
202406 95.572 108.200 99.547
202409 41.938 108.900 43.401
202412 49.120 110.700 50.007
202503 38.790 111.100 39.349
202506 24.745 111.700 24.967
202509 14.675 112.000 14.767
202512 86.580 113.000 86.350
202603 65.800 112.700 65.800

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of 円125.68 mean?
Zeria Pharmaceutical Co (TSE:4559) has a E10 of 円125.68 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Zeria Pharmaceutical Co and its competitors.
Is Zeria Pharmaceutical Co's E10 too high?
Zeria Pharmaceutical Co's current E10 is 円125.68. Overall, Zeria Pharmaceutical Co has a GF Score™ of 85/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zeria Pharmaceutical Co's E10 compare to ZTS and UTHR?
Zeria Pharmaceutical Co's E10 of 円125.68 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Zeria Pharmaceutical Co and its competitors. Zeria Pharmaceutical Co's current E10 is 円125.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zeria Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Zeria Pharmaceutical Co (TSE:4559) is currently considered Modestly Undervalued. The stock's GF Value™ is 円2,506.68, compared to a current price of 円2,087.00 — trading 16.7% below its estimated fair value. The current E10 is 円125.68. Zeria Pharmaceutical Co's overall GF Score™ is 85/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Zeria Pharmaceutical Co (TSE:4559), the current E10 is 円125.68 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zeria Pharmaceutical Co (TSE:4559) Overvalued in 2026?

Based on GuruFocus' analysis, Zeria Pharmaceutical Co stock appears to be undervalued. The current stock price of 円2,087.00 is trading 16.7% below its estimated GF Value™ of 円2,506.68. GuruFocus considers Zeria Pharmaceutical Co to be Modestly Undervalued.

Key valuation signals for TSE:4559:

  • E10: 円125.68
  • GF Value™: 円2,506.68 vs. price of 円2,087.00 (16.7% below fair value)
  • GF Score™: 85/100 with 2 warning signs

No single metric tells the full story. See the TSE:4559 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Zeria Pharmaceutical Co Business Description

Address 10-11, Nihonbashi Kobuna-cho, Tokyo, JPN, 103-8351
Zeria Pharmaceutical Co Ltd is a Japanese pharmaceutical company. The company through its subsidiaries engages in two business divisions which include ethical pharmaceutical products and consumer healthcare products business division. It principally manufactures, sells, imports and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural chemicals, industrial chemicals, reagents, cosmetics, health foods, alcoholic beverages, soft drinks, food additives, livestock feed, hygienic goods, medical devices, and health equipment.
85GF Score

Get the complete analysis for TSE:4559

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円2,087.00
Price
円2,506.68
GF Value